Cholesterol Medications (Statins & More) to Know
Cholesterol drugs are one of the easiest groups to learn because the statins — the dominant class — all share the same ending. Atorvastatin is the single most-dispensed drug on many lists, so this is a rewarding group to study early.
Study tip
The -statin ending is the giveaway: atorvastatin, rosuvastatin, simvastatin, pravastatin. Learn the statins as one block, then add the few non-statin agents (such as ezetimibe) separately.
High cholesterol drug list (12)
By generic name, ordered by how commonly each is dispensed.
| # | Generic name | Commonly used for |
|---|---|---|
| 1 | Atorvastatin | High Cholesterol |
| 17 | Rosuvastatin | High Cholesterol |
| 22 | Simvastatin | High Cholesterol |
| 34 | Pravastatin | High Cholesterol |
| 233 | Colesevelam | High Cholesterol |
| 234 | Ezetimibe | High Cholesterol |
| 235 | Evolocumab | High Cholesterol |
| 236 | Fenofibrate | High Cholesterol |
| 237 | Gemfibrozil | High Cholesterol |
| 240 | Cholestyramine | High Cholesterol |
| 241 | Lovastatin | High Cholesterol |
| 242 | Colestipol | High Cholesterol |
Study high cholesterol drugs for free
Turn this list into spaced-repetition flashcards. Create a free account and your progress saves automatically.
Frequently asked questions
- What is a statin?
- Statin is the drug class that lowers LDL cholesterol, and every statin's generic name ends in -statin (atorvastatin, rosuvastatin, simvastatin). The shared ending makes the class easy to recognize.
- Which cholesterol drug is the most common?
- Atorvastatin frequently ranks as the single most-dispensed drug overall, making it an essential first card.
More drug categories
Educational study aid — not medical advice. Learn My Drugs is a memorization tool for pharmacy students, technicians, and exam prep. Drug names and uses on this page are simplified for studying and are not a substitute for professional judgment. For clinical, dosing, or safety information, consult the official label and a licensed professional.
Authoritative references: DailyMed, MedlinePlus, and the U.S. FDA.
Last reviewed: May 30, 2026.